Page last updated: 2024-10-28

lidocaine and Anti-Phospholipid Antibody Syndrome

lidocaine has been researched along with Anti-Phospholipid Antibody Syndrome in 1 studies

Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kohno, Y1
Koishi, K1
Fujii, T1
Nishiyama, T1

Other Studies

1 other study available for lidocaine and Anti-Phospholipid Antibody Syndrome

ArticleYear
[A case report of ultrasound guided peripheral nerve block for lower extremity amputation of a patient with anti-phospholipid syndrome].
    Masui. The Japanese journal of anesthesiology, 2013, Volume: 62, Issue:6

    Topics: Amides; Amputation, Surgical; Antiphospholipid Syndrome; Female; Humans; Leg; Lidocaine; Middle Aged

2013